Skip to Content

C2T2 News

Latest News

Precision medicine already changing cancer treatment strategies

The ability to test patients' cancers for individual differences, mainly at the genetic level, and to make treatment decisions based on those differences is the hallmark of precision medicine, and Vanderbilt University Medical Center (VUMC) is among the leaders of this new approach to diagnosis and treatment. Read more...

Visit our news feed for the latest news from the Center for Cancer Targeted Therapies

C2T2 Newsletter

The C2T2 monthly newsletter informs referring physicians about the center's objectives, activities, and high-priority, early phase clinical trials.

Weekly Trial Updates

Weekly updates on early-phase clinical trials for Vanderbilt facultyand staff